Traitment of Patients Presenting Pemphigus With Anti CD20 (Mabthera).

University Hospital, Rouen2 个研究点分布在 1 个国家目标入组 22 人开始时间: 2003年6月1日最近更新: 2013年6月18日

适应症

试验速览

阶段: 2 期
状态: 已完成
发起方
入组人数: 22
试验地点: 2
主要终点: primary end-point was the rate of CR three months after the last infusion of Rituximab

研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

to treat in an open non comparative clinical study patients presenting pemphigus with corticodependance, corticoresistance and contre-indication to systemic steroids.

研究设计

研究类型: Interventional
分配方式: Non Randomized
干预模型: Single Group
主要目的: Health Services Research
盲法: None

入排标准

年龄范围: 18 Years 至 —（Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

•pemphigus corticoresistant
•pemphigus cortico dependant
•contre-indications : systémic steroids

排除标准

•age < 18
•cardiopathie
•pregnant woman
•absence contraception
•no consentment

结局指标

主要结局

primary end-point was the rate of CR three months after the last infusion of Rituximab

次要结局

secondary end-points were :
rate of CR during the study period
time from the start of Rituximab to CR
number and length of time to relapses
treatment tolerance

研究者

发起方

University Hospital, Rouen

申办方类型

Other

责任方

Sponsor

研究点 (2)

Loading locations...

相似试验

已完成

2 期

Azathioprine Versus Placebo in Pemphigus Vulgaris Treated With PrednisolonePemphigus Vulgaris

NCT00626678Tehran University of Medical Sciences48

已完成

1 期

Safety Study of PI-0824 to Treat Pemphigus VulgarisPemphigus Vulgaris

NCT00063752Peptimmune15

已完成

2 期

A Study of PRN1008 in Adult Patients With Pemphigus VulgarisPemphigus Vulgaris

NCT02704429Principia Biopharma, a Sanofi Company42

Unknown

2 期

Clinical Evaluation of New Treatment Strategy of Mucous Membrane Pemphigoid Using Large Dose of Prednisolone Plus Intra-lesional of Triamcinolone Acetonide Followed by Combination of Mycophenolate Mofetil, Dapsone and Low Dose PrednisoloneBenign Mucous Membrane Pemphigoid

NCT04744623Tanta University10

已完成

不适用

Identification of Vulnerability Factors in the Course of Pemphigus PatientsDermatological DiseasePemphigus

NCT02237313University Hospital, Rouen48